Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder

Authors:

Abstract
Autism spectrum disorder (ASD) is a common lifelong neurodevelopmental condition with an increasing global prevalence.1,2 The core symptoms of ASD are defined as difficulties in social communication/interaction and restrictive/repetitive behaviors.2 ASD is etiologically, biologically, and clinically heterogeneous; the genetic and environmental factors involved are still poorly understood.3 Current US Food and Drug Administration–approved medications do not target the core symptoms of ASD.4 There is an unmet need for approved pharmacologic therapies targeting the suspected underlying biologic pathways associated with the core symptoms of ASD.5

This publication has 31 references indexed in Scilit: